Suchergebnisse - "Chau, Ian"

PubPharm (11)

1

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

enthalten in: The lancet / Oncology | 2016

von Suker, M. | Beumer, B. | Sadot, E. | +17

2

Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial

enthalten in: The lancet / Oncology | 2016

von Antonia, S. | López-Martin, J. | Bendell, J. | +21

3

Colorectal cancer trial endpoints: time for dynamic thinking?

enthalten in: The lancet / Oncology | 2016

von Davidson, M. | Chau, I.

4

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

enthalten in: The lancet / Oncology | 2015

von Zhu, A. | Park, J. | Ryoo, B. | +17

5

Guidance on the management of diarrhoea during cancer chemotherapy

enthalten in: The lancet / Oncology | 2014

von Andreyev, J. | Ross, P. | Donnellan, C. | +10

6

Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trial

enthalten in: The lancet / Oncology | 2014

von Ford, H. | Marshall, A. | Bridgewater, J. | +15

7

Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial

enthalten in: The lancet / Oncology | 2013

von Seymour, M. | Brown, S. | Middleton, G. | +18

8

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

enthalten in: The lancet / Oncology | 2013

von Waddell, T. | Chau, I. | Cunningham, D. | +18

9

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

enthalten in: The lancet / Oncology | 2010

von Chua, Y. | Barbachano, Y. | Cunningham, D. | +7

10

Bevacizumab-associated gastrointestinal perforation

enthalten in: The lancet / Oncology | 2009

von Chau, I. | Cunningham, D.